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Abstract  
Mast cells are thought to participate in a wide variety of pathophysiological conditions. 
Mechanisms of regulation, however, of mast cell production and maturation are still to be 
elucidated. Mast cell developmental process is likely to be profoundly affected by 
cell-autonomous transcriptional regulators such as GATA family and CCAAT/enhancer 
binding protein (C/EBP) family members. Extracellular regulators such as stem cell factor and 
interleukin-3 have essential roles in basal and inducible mast cell generation, respectively. The 
relationship, however, between the extracellular signaling and cellular transcriptional control 
is unclear, and the trigger of the mast cell development remains elusive. Notch signaling plays 
a fundamental role in the lymphopoietic compartment, but its role in myeloid differentiation is 
less clear. Here we demonstrate that Notch signaling connects environmental cues and 
transcriptional control for mast cell fate decision. Delta1, an established Notch ligand, 
instructs bone marrow common myeloid progenitors (CMPs) and granulocyte-macrophage 
progenitors (GMPs) toward mast cell lineage at the expense of other granulocyte-macrophage 
lineages, depending on the function of the Notch2 gene. Notch2 signaling results in the 
upregulation of Hes-1 and GATA3, while simultaneous overexpression of these transcription 
factors remarkably biases the progenitor fate toward the mast  
cell-containing colony-forming cells. C/EBPα mRNA was downregulated in myeloid  
progenitors as a consequence of Hes-1 overexpression, in agreement with the recent proposal 
that the downregulation of C/EBPα is necessary for mast cell fate determination.  
Taken together, signaling through Notch2 determines the fate of myeloid progenitors toward 
mast cell-producing progenitors, via coordinately upregulating Hes-1 and GATA3.  
Introduction  
Mast cells are thought to participate in a wide variety of physiologic and pathologic processes
In addition to their involvement in allergic disorders and protective immune responses to 
parasites, mast cells are important in a broader sense in both innate and acquired immunity (1, 
2). Mast cells migrate from the bone marrow at an immature differentiation stage and 
complete the maturation process in the peripheral tissues under the influence of local growth 
and differentiation factors (2). These environmental cues tailor the mast cell phenotype to 
carry out functions specific to each peripheral tissue. The main factors influencing mast cell 
number and phenotype include stem cell factor (SCF), which is a ligand for c-Kit, 
interleukin-3 (IL-3), and T helper type II (Th2) -associated cytokines, such as IL-4 and IL-9 
(2). Signal transduction through the phosphatidylinositol 3 kinase pathway, Ras-mitogen 
activated protein kinase pathway, Janus kinase-signal transducer and activators of 
transcription pathway (3), etc., in the presence of IL-3 and SCF, might coordinate the 
lineage-specific transcription factors, but there is a disconnect between our understanding of 
cytokine signaling and transcription factor regulation. The generation of mast cells has been 
shown to be  
dependent on cooperative interplay between regulatory proteins: PU.1 upregulation,  
GATA2 upregulation (4), and C/EBPα downregulation (5).  
Notch receptor-mediated signaling has a fundamental role in cell fate determination in a 
variety of animals. In the mammalian immune system, Notch signaling is involved in the 
commitment and differentiation of T cells, development of splenic marginal zone B cells, and 
differentiation and functional modulation of mature T cells (6, 7). Questions remain, however
about whether and how Notch signaling regulates immune cells other than T and B cells. To 
the best of our knowledge, there are only two reports describing the relationship between 
Notch signaling and mast cells. According to these papers, Jagged-1, a Notch ligand (8), and 
Notch2 (9), are highly expressed in mast cells.  
Here we demonstrate that Notch signaling has a significant role in mast cell development. 
Using Notch2–null bone marrow cells, we show that Notch2 signaling promotes cell fate 
determination of bone marrow progenitors toward the progenitors having mast cell 
differentiation capacity at the expense of those that lose it. Furthermore, we demonstrate that 
the coordinated regulation of two transcription factors, Ηes-1 and GATA3, determines mast 
cell fate under Notch signaling. Overexpression of Hes-1 in myeloid progenitors represses 
C/EBPα mRNA expression, in agreement with the  
proposal that the C/EBPα  downregulation provides essential condition for mast cell  
development (5).  
These findings suggest that Notch signaling, a key regulator of lymphocytes, more broadly
affects cells of the immune system through dynamic regulation of transcription factors.  
 Results Notch2-mediated signaling facilitates mast cell lineage development at the 
expense of granulocyte/macrophage development from both CMPs and GMPs in vitro 
We cultured isolated CMPs and GMPs in SCF, IL-3, IL-6, and TPO for 7 d with plate-fixed 
Delta1-Fc chimeric protein, a soluble Notch ligand. In the culture using control Fc protein, 
instead of Delta1-Fc, the vast majority of the cells were Gr1
+
Mac1
+ 
granulocytes/macrophages
Compared with this, Lin
-
c-Kit
+
FcεRI
+
 mast cells were highly enriched, while there were fewer 
Gr1
+
 or Mac1
+
 granulocytes/macrophages with Delta1-Fc (Fig. 1A). The cell number was not 
significantly different in the culture with Delta1-Fc from the culture with the control Fc 
protein on day 7, when the flowcytometric analysis was performed (Fig. 1B). As shown, time 
courses of cell growth were different between the cultures with Delta1-Fc and control, due to 
the difference in the differentiation fate. Morphological observation confirmed the conversion 
from granulocytes/macrophages with the control Fc to mast cells, which contained toluidine 
blue-positive granules, with Delta1-Fc (Fig. 1C). The expression level of mast cell-specific 
protease, mast cell protease-5 (mMCP5), was higher in Delta1-stimulted population compared 
with control (Fig. 1D).  
While all of Notch1, Notch2 and Notch3 are expressed in myeloid progenitors  
(Supplementary Fig. 1), Notch2 is known to be expressed in mast cells amongst Notch  
1-4 receptors (9). We sorted CMPs and GMPs from polyinosinic-polycytidylic ribonucleic 
acid (pIpC)-treated Mx-Cre x Notch2
flox/flox
 (N2-MxcKO) mice (10), and then stimulated with 
Delta1-Fc. The mast cell increase by Delta1-Fc was strikingly blunted with Notch2-null 
CMPs or GMPs, whereas the results obtained with littermate Notch2
flox/flox
 mice treated with 
pIpC were virtually the same as those obtained with wild-type mice (Fig. 1E; compare with 
Fig. 1A). These observations indicate that Notch2-mediated signaling plays a key role in 
derivation of mast cells from myeloid progenitor cells.  
Hes-1 is upregulated downstream of Notch signaling but insufficient for mast cell 
derivation  
Quantitative real-time PCR analysis revealed that Delta1-Fc treatment of CMPs or GMPs 
upregulated mRNA for Hes-1, a basic helix-loop-helix transcriptional repressor that often 
functions downstream of Notch signaling (11), within as little as 8 h (Fig. 2A). To investigate 
whether Hes-1 is a downstream effector of Notch signaling for mast cell enrichment by 
Delta1-Fc, we retrovirally expressed Hes-1 in CMPs and GMPs. Expression of the Hes-1 
protein was confirmed by a western blot analysis of the  
retrovirally infected NIH-3T3 cells (Fig. 2B). Derivation of the Lin
-
c-Kit
+
FcεRI
+
 mast cells, however, 
was not increased by Hes-1 expression after 8 d of culture (Fig. 2C), whereas there was a relative increase in Lin
-
c-Kit
+
FcεRI
-
cells. 
This observation indicated that the effect of Hes-1 expression on mast cell enrichment was not equivalent to that of Delta1-Fc 
stimulation, suggesting the presence of an effector molecule other than Hes-1 at the downstream of Notch.  
GATA3, but not GATA2, is a mediator downstream of Notch2 for mast cell
developmental decision, together with Hes-1 
Among the GATA family of transcription factors, GATA2, which is upregulated during
Notch-mediated inhibition of granulocytic differentiation (12, 13), is proposed to be a 
regulator of mast cell differentiation (4, 5, 14). Nevertheless, GATA2 expression levels in
CMPs or GMPs stimulated with Delta1-Fc were equal to or lower than those stimulated with 
control Fc protein during the first 48 h (Fig. 3A).  
GATA3 is a crucial transcription factor during T cell development. Recently, it was reported 
that its overexpression in double negative (DN) 1 and DN2 stage thymocytes blocked further 
T cell development, and unexpectedly, induced mast cells from these early thymocyte 
populations (15). Physiologic relevance between GATA3  
and mast cell generation, however, is yet to be elucidated. Delta1-Fc stimulation of CMPs 
and GMPs substantially increased GATA3 mRNA during a relatively later time course (Fig. 
3B). This finding suggests that GATA3 is a possible target of Notch signaling, albeit indirect, 
for mast cell production.  
Thus, we examined whether Hes-1 and GATA3 are bona fide effectors functioning 
downstream of Notch signaling for mast cell production, by retrovirally transducing CMPs 
and GMPs with these genes (Fig, 3C and D). Both CMP- and GMP-derived fractions 
expressing Hes-1 alone (with the NGFR marker) gave rise to populations very similar to 
those derived from the fraction expressing Hes-1 with the GFP marker (Fig. 2C, 3C, and 3D). 
There was no consistent increase in the c-Kit
+
FcεRI
+
mast cell population at day 8, although it 
appears that Hes-1 single positive CMP-derived fraction gave rise to this population slightly 
more than control in Fig. 3C and D. On the contrary, the Hes-1 single positive fractions gave 
rise to fewer mast cells than the control virus-infected fractions at the later time course (data 
not shown). In the fractions expressing GATA3 alone (with the GFP marker), the 
c-Kit
+
FcεRI
+
 mast cell population only marginally, although reproducibly, increased 
compared with controls (Fig. 3C and D).  
In contrast to these, the c-Kit
+
FcεRI
+
 mast cell population was markedly  
enriched in the Hes-1 and GATA3 double positive fractions at day 8 after the infection  
of CMPs and GMPs compared with either mock, or Hes-1 or GATA3 single positive 
fractions (Fig. 3C and D).  
We reproducibly observed increase in the c-Kit
+
FcεRI
-
population, which might represent the 
expanded progenitors maintaining the immature state, in the Hes-1 single positive fractions. 
The c-Kit
-
FcεRI
+
 population, whose identification is unknown, variably increased in the 
GATA3 single positive fractions compared with controls (Fig. 3C).  
When plated in methylcellulose after the retroviral infection, Hes-1- and 
GATA3-co-expressing CMPs and GMPs formed large and monotonous cell-containing 
colonies (plating efficiency, ~20% in CMPs and <10% in GMPs); staining indicated that 
more than 80% of colonies contained mast cells, positive for toluidine blue, as the major 
population (Fig. 3 E, F, and G), while the plating efficiency was comparable to that with 
mock introduction (Fig. 3E).  
These observations indicate that the simultaneous expression of GATA3 and Hes-1 biased 
the cell fate of myeloid progenitors toward the downstream progenitors having mast 
cell-generating capacity at the single cell level, rather than that those transcription factors 
expanded the pool of mast cell progenitors or mast cells.  
Hes-1 upregulation causes C/EBPα downregulation C/EBPα is a critical transcription 
factor for myeloid differentiation (16), and its downregulation cooperates with the 
upregulation of a GATA transcription factor to instruct mast cell development (5). At 48 h 
after the initiation of Hes-1 retroviral transduction, C/EBPα mRNA was downregulated in 
both CMPs and GMPs (Fig. 4A). The C/EBPα mRNA level was also markedly suppressed in 
a mouse myeloid cell line 32D that stably expressed exogenous Hes-1 (Fig. 4B). These 
findings suggest that the C/EBPα downregulation is the major outcome of Hes-1 upregulation 
induced by Delta1-Notch2 signaling in the myeloid progenitors.  
Discussion  
In the present study, we demonstrate that Notch2-mediated signaling has a significant role in 
the mast cell derivation from myeloid progenitors such as CMPs and GMPs. This biological 
effect is probably mediated through coordinated upregulation of Hes-1 and GATA3 through 
Notch2 signaling; Hes-1 upregulation further results in C/EBPα downregulation, which is 
important for the blockade of myeloid lineage differentiation. It is not unexpected that Hes-1 
upregulation plays a role in the execution of Notch2  
signaling, given the fact that Hes-1 is an established target of Notch signaling in a  
number of cell systems (17). However, we show in this paper that Hes-1 upregulation 
represents only a part of signaling downstream of Notch activation. Exogenous Hes-1 
expression in CMPs and GMPs resulted in the increase of Lin
-
c-Kit
+
FcεRI
-
cells; obviously 
different from the Lin
-
c-Kit
+
FcεRI
+
mast cell enrichment that was seen by the Delta1 
stimulation. Although the identity of the Lin
-
c-Kit
+
FcεRI
-
cells is yet to be determined, these 
cells may contain immature myeloid progenitors which could differentiate into mast cells i
 
f
GATA3 would co-exist, while granulocytes/macrophages if other critical molecules (such as 
C/EBPα) would.  
We identified GATA3, not GATA2, upregulation that complements Hes-1 upregulation and 
creates a part of Notch signaling. Involvement of GATA2 is proposed to be important for
inhibiting granulocytic differentiation downstream of Notch signaling in both the 32D cell
line (13) and mouse hematopoietic progenitor cells (12). Furthermore, GATA2 is required for
in vitro mast cell generation (4, 14), and enforced expression of GATA2 instructs the
C/EBPα-deficient myeloid progenitors as well as common lymphoid progenitors to become
mast cells in vitro (5). Our conclusion might appear to be inconsistent with these lines of
papers. We confirmed that the enforced GATA2 and Hes-1 co-expression in CMPs and GMPs 
resulted in predominant mast cell  
generation in a manner indistinguishable from that of GATA3 and Hes-1 co-expression  
(data not shown). This indicates that GATA2 and GATA3 have redundant properties when 
they are expressed exogenously. The result of colony formation assay from CMPs and GMPs 
with enforced GATA3 and Hes-1 expression indicates that the mast cell derivation is based 
on the cell fate alteration made in the individual progenitor cells. Because the biological 
readout for Notch ligand stimulation was virtually the same as that for the GATA3 and Hes-1 
co-expression, the substantial mast cell generation at day 7 with Delta1-Fc is likely to be 
mainly caused by biased cell fate decision in the myeloid progenitors.  
In a different line, the introduction of GATA3 alone to thymocytes was recently reported to
result in mast cell generation (15). Although this report might appear to be inconsistent with
our data, the difference in the starting cell populations could cause the different results. We
conclude that the Hes-1 expression, and probably subsequent C/EBPα downregulation, is 
required, though not sufficient, for mast cell generation from CMPs and GMPs. In contrast,
C/EBPα is already downregulated in thymocytes at the DN1 and DN2 stages (18), and thus, 
introduction of GATA3 might be sufficient for mast cell generation from early thymocytes.
As for the relationship between GATA3 and Notch signaling, both Notch1 and Notch2 are
important for the generation of Th2  
cells, and act by directly inducing transcription of GATA3 and IL-4 (19, 20) It is,  
however, unclear whether such a direct regulation is applicable to cells in other lineages. In
our observation, GATA3 was upregulated by Delta1-Fc at 48 h but not at 8 h in CMPs and 
GMPs, making it obscure whether GATA3 is a direct target of Notch signaling in these cells,
while the role of IL-4 in the regulation of GATA3 remains to be determined.  
We and others previously reported that enforced expression of Hes-1 in a 32D cell line inhibits 
granulocytic differentiation induced by granulocyte colony-stimulating factor (13, 21). In the 
present study, we demonstrated that C/EBPα downregulation occurs downstream of Hes-1 in 
both the 32D cell line and fresh CMPs and GMPs. C/EBPα repression by Hes-1 was 
previously shown to be among the mechanisms of Notch-Hes-1-mediated inhibition of 
adipogenesis from a preadipocyte cell line (22). Although less remarkable compared with 
Hes-1 overexpression, Delta1-Fc stimulation also induced C/EBPα repression, in a time course 
after Hes-1 upregulation. This suggests that the physiologic Hes-1 up-regulation is sufficient 
for C/EBPα repression (data not shown). Our data, thus, support a new paradigm that the 
Notch-Hes-1-C/EBPα  axis consists of a common pathway for differentiation inhibition in a 
variety of cell lineages.  
It was recently suggested that downregulation of C/EBPα followed by  
upregulation of a GATA factor orchestrates mast cell differentiation from myeloid 
progenitors (5). This could be true, but importantly, we demonstrated that such a balanced 
regulation of transcription factors is a result of environmental signaling through Notch2, 
rather than a cell-autonomous operation (Fig. 4C).  
The physiological significance of Notch2-mediated cell fate bias toward mast cell lineage 
remains to be determined, because mast cells were not depleted in naïve status in N2-MxcKO 
mice (M. S.-Y. and S.C., unpublished data). Cultured mast cells were also generated from 
Notch2-null bone marrow cells as efficiently as wild-type bone marrow cells. Notably, mast 
cells are not depleted in mice lacking IL-3 gene, while IL-3 is the most potent mast cell 
developmental factor in vitro. However, IL-3-deficient mice are defective in mast 
cell-mediated intestinal nematode eradication. The pathways and mechanisms responsible for 
regulating mast cell progenitor recruitment and trafficking are likely to be dynamic and 
susceptible to modification during inflammation (1). Similarly, Notch2 is required for the 
proper resonse of mast cells during nematode infection. (M.S.-Y. and S.C.; unpublished 
observation.) Notch2-mediated mast cell derivation might also be required for such 
pathological settings, while it is unnecessary for the steady state mast cell generation.  
Materials and Methods  
Mice  
Notch2
flox/flox
 mice were described previously (10). Mx-Cre transgenic mice (23) were 
Notch2
flox/flox 
crossed with  mice and the progeny were injected with pIpC (Sigma-Aldrich) 7 times every 
other day from 3 d after birth (25 μg/g body weight) or 3 times between 4 and 6 wk of age (20 
μg/g body weight). All experiments were done in accordance with our Institutional 
Guidelines.  
Myeloid progenitors  
Bone marrow cells from each mouse strain studied were incubated with biotinylated antibodies
for lineage markers including anti-CD3, anti-CD4, anti-CD8, anti-B220, anti-Ter119, and 
anti-Gr-1 antibodies (BD Pharmingen) followed by incubation with streptavidin Micro Beads
(Miltenyi Biotec). The lineage marker-negative fraction was separated with an autoMACS
separator (Miltenyi Biotec), and incubated with anti-CD34-FITC, anti-CD16/32 (FcγIII/II 
receptor)-PE, anti-c-Kit-APC, streptavidin PerCP (BD Pharmingen), and anti-Sca1-PE/Cy7 
(eBioscience).  
Lin
-
c-Kit
+
Sca1
-
FcγR
lo
CD34
+
 and Lin-c-Kit
+
Sca1
-
FcγR
hi
CD34
+
cells (CMPs and GMPs, 
respectively (24) were sorted by a FACSAria cell sorter (Becton Dickinson).  
Ligand fixation  
Delta1-Fc was described previously (25). A 24-well non-tissue culture plate (Nalge Nunc) 
was coated with 10 μg/mL of rabbit anti-human IgG (DAKO), blocked with 20% fetal bovine
serum (FBS) -containing RPMI-1640 medium (Sigma-Aldrich), and washed with 
phosphate-buffered saline. The Delta1-Fc (3.5 µg/mL) or Fc portion of human IgG (2 µg/mL, 
Fc protein, ART or Jackson Immuno Research Laboratories) was then incubated for 30 min
and supernatants were removed.  
Ligand stimulation of myeloid progenitors 
Sorted CMPs or GMPs were cultured in Delta1-Fc or control Fc protein-fixed plates in 20% 
FBS containing Iscove’s modified Dulbecco’s medium (Sigma-Aldrich), supplemented with 
50 ng/mL SCF, 20 ng/mL IL-3 (Peprotech), 20 ng/mL IL-6, and 20 ng/mL TPO (gifts from 
Kirin Brewery Research Laboratory). On day 7, the cells were incubated with purified isotype
IgE (BD Pharmingen) after blocking the Fcγ receptor with anti-CD16/32 (Fcγ III/II receptor) 
antibody (BD Pharmingen), stained with  
anit-IgE-FITC, -Gr-1-PE, -Mac1-PE (BD Pharmingen), and -c-Kit-APC, and then  
analyzed by FACSCalibur (Becton Dickinson). Cells cultured for 7 days were also
characterized by Wright-Giemsa staining or toluidine blue staining (pH 0.5) on cytospin 
slides. In some experiments, mRNA was prepared at the indicated time points and quantified
by real-time PCR, as described below.  
Retroviral transduction  
Hes-1 cDNA, a gift from R. Kageyama, was subcloned into a retrovirus vector, 
GCDNsam/IRES-nerve growth factor receptor (NGFR), a gift from H. Nakauchi and M. 
Onodera. cDNAs for GATA3, a gift from S. Takahashi, and Hes-1 were subcloned into 
pMYs/IRES-GFP, a gift from T. Kitamura. A retrovirus packaging cell line, PLAT-E (26), 
was transfected with each retrovirus vector using FuGENE 6 (Roche Diagnostics). The 
conditioned medium was concentrated and placed in a 24-well non-tissue culture dish for 4 h, 
pre-coated with 40 μg/mL of RetroNectin (Takara Bio) overnight at 4°C. Sorted CMPs or 
GMPs were then plated for infection in the presence of 20% FBS, 50 ng/mL SCF, 20 ng/mL 
IL-3, 20 ng/mL IL-6, and 20 ng/mL TPO. Green fluorescent proteins- and/or human 
NGFR-positive fractions were subjected to FACS analysis 8 d after infection. Otherwise, the 
infected cells were sorted at 48 h from the initiation of  
infection with a FACSAria (Becton-Dickinson) cell sorter and used for colony assay using 
Methocult M3231 (StemCell Technologies), supplemented with cytokines as described above
Hes-1 stably expressing 32D cell lines were previously described (13). To confirm the 
protein expression, NIH-3T3 cells were also infected with the same viral supernatants using 
polybrene (Sigma-Aldrich).  
RNA quantitation 
Total cellular RNA was extracted with RNeasy (Qiagen) and converted to cDNA with 
Superscript III (Invitrogen). GATA2, GATA3, C/EBPα, and mouse mast cell progease-5 
(mMCP-5) were analyzed with TaqMan Gene Expression assays (Applied Biosystems).
Hes-1 mRNA was measured as previously described (10). Real-time PCR was performed 
using the ABI PRISM 7000 Sequence Detection System (Applied Biosystems). All the data
were standardized with the 18s ribosomal RNA.  
Western blot analysis  
Virus-infected NIH-3T3 cells were solubilized in lysis buffer containing 1% Triton X-100. 
The Hes-1 and GATA3 proteins were detected by anti-Hes-1 antibody (H-140, Santa Cruz) 
and anti-GATA3 antibody (HG3-31), respectively.  
Statistical analysis 
Results from two or three independent experiments (n=2) of quantitative real-time PCR were 
analyzed by the Mann-Whitney test.  
Acknowledgement   
We thank Dr. R. Kageyama for the Hes-1 cDNA, Dr. S. Takahashi for the GATA3 cDNA; 
Dr. H. Nakauchi and Dr. M. Onodera for the GCDNsam/IRES-NGFR; Dr. T. Kitamura for 
the pMYs/IRES-GFP and PLAT-E; and Kirin Brewery Research Laboratory for the TPO and 
IL-6. We also thank Y. Mori for technical assistance. This work was supported in part by 
Grants-in-Aid for Scientific Research, KAKENHI (14370300 and 18659276) from the Japan 
Society for the Promotion of Science: a grant from the Sagawa Foundation for Promotion of 
Cancer Research.  
Authorship  
MSY designed and performed research, analyzed data, and wrote the paper. ENY performed 
research. TS, KK, KY, SO, and MK contributed to the work through vital discussion. SC was 
involved in designing research and wrote the paper with MSY. Correspondence: Department of 
Cell Therapy and Transplantation Medicine, University of Tokyo Hospital, 7-3-1 Hongo, 
Bunkyo-ku, Tokyo, Japan; e-mail: schiba-tky@umin.net.  
Figure Legends  
Fig.1 Notch2-mediated signaling facilitates mast cell lineage development at the expense 
of granulocyte/macrophage development from CMPs and GMPs in vitro. A, Sorted 
CMPs or GMPs of wild-type mice were cultured with plate-fixed Delta1-Fc chimeric protein 
or control Fc protein for 7 d in 50 ng/mL SCF, 20 ng/mL IL-3, 20 ng/mL IL-6, and 20 ng/mL 
TPO. FACS analysis showed FcεRI
+
c-Kit
+
Gr1
-
Mac1
-
 mast cells were highly enriched with 
Delta1-Fc, while Gr1
+
Mac1
+
 granolocytes and macophages were main population with control 
Fc protein.  
B, Cell growth in culture of CMPs and GMPs with Delta1-Fc or control Fc protein.  
C, Day 7 progeny of CMPs and GMPs were analyzed morphologically by cytospin. (Left 
panel) Wright-Giemsa staining; original magnification, x400. (Right panel) Toluidine blue 
staining; original magnification, x400. D, mRNA was extracted from day 7 progeny of CMPs 
and GMPs, reverse-transcribed and applied to quantitative real-time PCR analysis for mouse 
mast cell protease-5 (mMCP-5). Data are presented as mean +/- SD; n=4, p=0.0286 [CMPs, 
7d]; n=4, p=0.0286 [GMPs, 7d] (non parametric test). E, CMPs and GMPs of Mx-Cre x 
Notch2
flox/flox
 and littermate Notch2
flox/flox
 mice were cultured with Delta1-Fc or control Fc 
protein for 7 d in SCF, IL-3, IL-6, and TPO.  
Notch2-null CMPs and GMPs failed to respond to Delta1-Fc, whereas the results  
obtained with littermate mice treated with pIpC were virtually the same as those obtained 
with wild-type mice.  
Fig.2 Hes-1 upregulation downstream of Notch signaling is insufficient for mast cell 
derivation A, CMPs and GMPs were stimulated with plate-fixed Delta1-Fc protein or control 
Fc protein in SCF, IL-3, IL-6, and TPO. Cells were collected at 8 h and Hes-1 mRNA was 
measured by quantitative real-time PCR analysis. Hes1 mRNA was substantially upregulated 
with Delta1-Fc compared with control. Data are presented as mean +/- SD; n=4, p=0.0286 
[CMPs, 8h]; n=4, p=0.0286 [GMPs, 8h] (non parametric test). B, A retrovirus packaging cell 
line, PLAT-E, was transfected with cDNA-subcloned retrovirus vectors, i.e., 
Hes-1-GCDNsam/IRES-nerve growth factor receptor (NGFR), Hes-1-pMYs/IRES-GFP, and 
GATA3-pMYs/IRES-GFP, or a mock retrovirus vector. NIH-3T3 cells were infected with the 
conditioned medium using polybrene. The proteins were detected by anti-Hes-1 antibody 
(H-140, Santa Cruz) and anti-GATA3 antibody (HG3-31). C, CMPs and GMPs were 
retrovirally transduced with Hes-1-pMYs/IRES-GFP or mock  
virus. The proportion of c-Kit
+
FcεRI
+
 mast cells was not significantly increased by Hes-1 expression. The proportion 
of c-Kit
+
FcεRI
-
 cells, which probably represent myeloid progenitors, was always greater in the Hes-1-expressing population than 
control.  
Fig.3 GATA3, but not GATA2, is a mediator downstream of Notch2 for mast cell 
developmental decision, together with Hes-1 A, CMPs and GMPs were stimulated with 
plate-fixed Delta1-Fc in the presence of stem cell factor, interleukin (IL) -3, IL-6, and 
thrombopoietin for 8 h or 48 h. Cells were harvested and quantitative real-time PCR was 
performed. GATA2 mRNA levels were slightly decreased rather than increased by Delta1-Fc 
in GMPs at 8 h, and not significantly different in CMPs treated with Delta1-Fc and control Fc 
at 8 h or in CMPs and GMPs treated with Delta1-Fc and control Fc at 48 h. B, Quantitative 
real-time PCR analyses in CMPs and GMPs revealed that GATA3 mRNA was upregulated 
by Delta1-Fc at 48 h, but not at 8 h. Data are presented as mean +/- SD; n=4, p=0.6857 
[CMPs, 8 h]; n=4, p=0.0571 [GMPs, 8 h]; n=4, p=0.0286 [both CMPs and GMPs, 48 h] (non 
parametric test). C, CMPs and GMPs were retrovirally transduced with 
Hes-1-GCDNsam/IRES-NGFR  
and GATA3-pMYs/IRES-GFP, and subjected to FACS analysis 8 d after the infection.  
The c-Kit
+
FcεRI
+
 fraction was remarkably enriched in Hes-1 and GATA3 double positive 
fraction compared with the Hes-1 or GATA3 single positive fraction, or the mock 
virus-introduced fraction. D, The proportions of c-Kit
+
FcεRI
+
 fraction are depicted. Each 
diamond represents a data point. The bars represent +/- 2SD. CMP n=6; GMP n=4. E, NGFR 
and GFP double positive cells were sorted at 48 h after infection. Two hundred and fifty 
NGFR and GFP double positive CMPs and 1500 GMPs were plated per dish and cultured for 
7 d in methylcellulose, supplemented with SCF, IL-3, IL-6, and TPO. Hes-1- and 
GATA3-co-expressing cells formed mainly mast cell colonies, while mock virus transduced 
cells formed various colonies including granulocyte, macrophage or mixture of these cells. G, 
granulocyte colonies; M, macrophage colonies; mix, granulocyte/macrophage or mixed 
colonies; *, colonies mainly consisting of mast cells. The result of a representative 
experiment is shown (n=2). F, Wright-Giemsa staining of Hes-1 and GATA3 co-expressing 
colony-forming cells. Original magnification, x400. G, Toluidine blue staining of Hes-1 and 
GATA3 co-expressing colony-forming cells. Original magnification, x400.  
 Fig.4 Hes-1 upregulation causes C/EBPα downregulation A, CMPs and GMPs were 
retrovirally transduced with Hes-1-pMYs/IRES-GFP. GFP
+ 
cells were sorted 48 h after 
infection and were examined for C/EBPα mRNA by quantitative real-time PCR. C/EBPα 
mRNA in CMPs and GMPs was substantially reduced by Hes1 compared with mock virus 
transduction. Data are presented as mean +/- SD; n=5 [mock] or 4 [Hes-1], p=0.0159 [CMP]; 
n=5, p=0.0079 [GMP] (non parametric test). B, 32D cells stably transduced with Hes-1 and 
maintained in 5 ng/mL IL-3 were examined for C/EBPα expression. C/EBPα mRNA was 
reduced in Hes1-transduced clones compared with mock-transduced clones. Data were 
confirmed by experiments using two independent clones. Data are presented as mean +/- SD. 
C, Schematic model of Notch signaling in the mast cell system.  
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